Literature DB >> 18480547

Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma.

Keiichi Miyamoto1, Tomomi Kusumi, Fuyuki Sato, Hitoshi Kawasaki, Shigeru Shibata, Motonari Ohashi, Kenichi Hakamada, Mutsuo Sasaki, Hiroshi Kijima.   

Abstract

Claudins are transmembrane proteins and major constitutes of tight junctions, and participate in the paracellular barrior and cellular connecting functions. They have been shown to be differentially regulated in malignant tumors and play a role in carcinogenesis and tumor progression. Recent studies have shown changes in expression of claudins during tumorigenesis. However, a causal relationship between claudin expression and cancer recurrent status has not been established. In this study, we examined 54 esophageal cancer cases to assess immunohistochemical expression patterns of claudin-1. Eleven (20.4%) of 54 cases had negative immunostaining for claudin-1. Decreased expression of claudin-1 was statistically correlated with recurrence status (P = 0.018). The cases with lymphatic vessel permeation showed reduced expression patterns of claudin-1 (P = 0.033). Decreased expression of claudin-1 was also correlated with short diseasefree survival (P = 0.0003) and overall survival (P = 0.0045). The results indicated that claudin-1 expression was correlated with the recurrence status and poor prognosis in esophageal cancer and claudin-1 expression may be a good indicator of recurrence in esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480547     DOI: 10.2220/biomedres.29.71

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  20 in total

1.  Expression pattern of claudins 1 and 3-an auxiliary tool in predicting behavior of mucoepidermoid carcinoma of salivary gland origin.

Authors:  Katri Aro; Luiz Eduardo Blumer Rosa; Ibrahim O Bello; Ylermi Soini; Antti A Mäkitie; Tuula Salo; Ilmo Leivo
Journal:  Virchows Arch       Date:  2010-12-24       Impact factor: 4.064

Review 2.  Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.

Authors:  Danila Coradini; Claudia Casarsa; Saro Oriana
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

3.  Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder.

Authors:  Péter Törzsök; Péter Riesz; István Kenessey; Eszter Székely; Aron Somorácz; Péter Nyirády; Imre Romics; Zsuzsa Schaff; Gábor Lotz; András Kiss
Journal:  J Histochem Cytochem       Date:  2011-11       Impact factor: 2.479

4.  The prognostic role of claudins in head and neck squamous cell carcinomas.

Authors:  Györgyi A Nelhűbel; Boróka Károly; Balázs Szabó; Gábor Lotz; András Kiss; József Tóvári; István Kenessey
Journal:  Pathol Oncol Res       Date:  2013-07-12       Impact factor: 3.201

5.  Claudins 1, 3M, 3S, 4, 5 and 7 in vulvar neoplasms compared with vulvar squamous cell carcinoma.

Authors:  Milla Riski; M Santala; Y Soini; A Talvensaari-Mattila
Journal:  Tumour Biol       Date:  2011-12-16

6.  Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance.

Authors:  Abderrahman Ouban
Journal:  Histol Histopathol       Date:  2021-02-25       Impact factor: 2.303

7.  Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.

Authors:  Yvonne Myal; Etienne Leygue; Anne A Blanchard
Journal:  J Biomed Biotechnol       Date:  2010-05-13

8.  Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?

Authors:  Mo Shi; Zhou Wang; Liang Song; Dong Wang; Zhi Sun
Journal:  Med Oncol       Date:  2014-04-16       Impact factor: 3.064

9.  Claudin-20 promotes an aggressive phenotype in human breast cancer cells.

Authors:  Tracey A Martin; Jane Lane; Hulya Ozupek; Wen G Jiang
Journal:  Tissue Barriers       Date:  2013-09-20

Review 10.  Claudins as biomarkers of differential diagnosis and prognosis of tumors.

Authors:  Olga P Popova; Alla V Kuznetsova; Svetlana Yu Bogomazova; Alexey A Ivanov
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-09       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.